title: Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner.
abstract: Impairments in bioenergetic function, cellular resiliency, and structural plasticity are associated with the pathogenesis of mood disorders. Preliminary evidence suggests that creatine, an ergogenic compound known to promote cell survival and influence the production and usage of energy in the brain, can improve mood in treatment-resistant patients. This study examined the effects of chronic creatine supplementation using the forced swim test (FST), an animal model selectively sensitive to antidepressants with clinical efficacy in human beings. Thirty male (experiment 1) and 36 female (experiment 2) Sprague-Dawley rats were maintained on either chow alone or chow blended with either 2% w/w creatine monohydrate or 4% w/w creatine monohydrate for 5 weeks before the FST. Open field exploration and wire suspension tests were used to rule out general psychostimulant effects. Male rats maintained on 4% creatine displayed increased immobility in the FST as compared with controls with no differences by diet in the open field test, whereas female rats maintained on 4% creatine displayed decreased immobility in the FST and less anxiety in the open field test compared with controls. Open field and wire suspension tests confirmed that creatine supplementation did not produce differences in physical ability or motor function. The present findings suggest that creatine supplementation alters depression-like behavior in the FST in a sex-dependent manner in rodents, with female rats displaying an antidepressant-like response. Although the mechanisms of action are unclear, sex differences in creatine metabolism and the hormonal milieu are likely involved.
authors.affiliation: Department of Psychology, Tufts University, Medford, MA, USA.
authors.forename: Patricia J
authors.initials: PJ
authors.lastname: Allen
authors.forename: Kristen E
authors.initials: KE
authors.lastname: D'Anci
authors.forename: Robin B
authors.initials: RB
authors.lastname: Kanarek
authors.forename: Perry F
authors.initials: PF
authors.lastname: Renshaw
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects / Q000502:physiology; D003401:Creatine / Q000008:administration & dosage* / Q000494:pharmacology; D003863:Depression / Q000178:diet therapy* / Q000503:physiopathology; D004195:Disease Models, Animal; D005106:Exploratory Behavior / Q000187:drug effects / Q000502:physiology; D005260:Female; D046353:Immobility Response, Tonic / Q000187:drug effects; D008297:Male; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects; D012727:Sex Characteristics; D013550:Swimming
chemical_list: D000928:Antidepressive Agents; D003401:Creatine